By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

AstraZeneca PLC 

15 Stanhope Gate

London  England  W1K 1LN  United Kingdom
Phone: 44-20-7304-5000 Fax: 44-20-7304-5151


SEARCH JOBS

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas – Respiratory and Autoimmunity, Cardiovascular and Metabolic Diseases, and Oncology. The company is also active in inflammation, infection and neuroscience through numerous collaborations. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.

YEAR FOUNDED:

1999

LEADERSHIP:

CEO: Pascal Soriot

CFO: Marc Dunoyer

CMO: Marc Dunoyer

CTO: Andrew Chen

CCO: Katarina Ageborg

CMO: Sean Bohen

CLINICAL TRIAL:

Please click here for clinical trial information.

JOB OPPORTUNITY:

Please click here for AstraZeneca job opportunities.

PRODUCTS:

AstraZeneca Medications

For more information, visit
www.astrazeneca.com and follow us on www.twitter.com/astrazeneca.

FOLLOW BLANK:





Key Statistics


Email:
Ownership: Public

Web Site: AstraZeneca PLC
Employees: 50,000 worldwide
Symbol: AZN
 









Company News
New FDA Report Cites 22 Drugs That Passed Phase II But Crashed and Burned in Phase III 1/20/2017 5:42:12 AM
GlaxoSmithKline (GSK) Poaches AstraZeneca PLC (AZN) Exec to Replace Exiting Pharma Head 1/19/2017 5:27:13 AM
AstraZeneca PLC (AZN) Release: Biopharma Rejigs Primary Endpoints for Mystic Lung Cancer Trial 1/17/2017 5:51:12 AM
Meet AstraZeneca PLC (AZN)'s New Head of Oncology 1/12/2017 6:08:53 AM
How AstraZeneca PLC (AZN) CIO Makes IT Twice As Good At Half The Cost 1/5/2017 7:50:18 AM
Pfizer (PFE) Completes Acquisition Of Small Molecule Anti-Infective Business From AstraZeneca PLC (AZN) 12/27/2016 11:19:14 AM
Ionis Pharma (IONS) And AstraZeneca PLC (AZN) Advance First Generation 2.5 LICA Drug Into Preclinical Development To Treat Cardiovascular Disease 12/20/2016 9:11:41 AM
AstraZeneca PLC (AZN) Exec Jumps Ship to Become Innate Pharma (IPH.PA ) CEO 12/19/2016 6:37:38 AM
AstraZeneca PLC (AZN) Nabs Rights to KRAS Drug in $165 Million Ionis Pharma (IONS) Deal 12/16/2016 7:51:50 AM
Alexion (ALXN) CEO and CFO Abruptly Step Down, Former AstraZeneca PLC (AZN) CEO Named New Leader 12/12/2016 6:12:43 AM
12345678910...
//-->